Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors - Concepedia

Concepedia

Publication | Open Access

Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors

DOI Full Paper Access

380

Citations

33

References

2008

Year

Ruth Plummer, Christopher J. Jones, Mark R. Middleton, Richard H. Wilson, Jeffrey Evans, Anna L Olsen, Nicola J. Curtin, Alan V. Boddy, Peter J. McHugh, David R. Newell,

Clinical Cancer Research

Abstract

The combination of AG014699 and temozolomide is well tolerated, pharmacodynamic assessments showing proof of principle of the mode of action of this new class of agents.

References

	Year	Citations

Page 1